Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome.
Cardiolipin (CL) and phosphatidylglycerol (PG) are the major polyglycerophospholipids observed in mammalian tissues. CL is exclusively found in the inner mitochondrial membrane and is required for optimal function of many of the respiratory and ATP-synthesizing enzymes. The role of CL in oxidative phosphorylation is, however, not fully understood and although reduced CL content leads to aberrant cell function, no human disorders with a primary defect in cardiolipin metabolism have been described. In this paper we present evidence that patients with the rare disorder X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060) have a primary defect in CL and PG remodeling. We investigated phospholipid metabolism in cultured skin fibroblasts of patients and show that the biosynthesis rate of PG and CL is normal but that the CL pool size is 75% reduced, indicating accelerated degradation. Moreover, the incorporation of linoleic acid, which is the characteristic acyl side chain found in mammalian CL, into both PG and CL is significantly reduced, whereas the incorporation of other fatty acids into these phospholipids is normal. We show that this defect was only observed in Barth syndrome patients' cells and not in cells obtained from patients with primary defects in the respiratory chain, demonstrating that the observed defect is not secondary to respiratory chain dysfunction. These results imply that the G4.5 gene product, which is mutated in Barth syndrome patients, is specifically involved in the remodeling of PG and CL and for the first time identify an essential factor in this important cellular process.
Vreken
P
P
Department of Clinical Chemistry, Academic Medical Center, Amsterdam, 1100 DE, The Netherlands. p.vreken@amc.uva.nl
Valianpour
F
F
Nijtmans
L G
LG
Grivell
L A
LA
Plecko
B
B
Wanders
R J
RJ
Barth
P G
PG
D002308:Cardiolipins / Q000378:metabolism*; D002311:Cardiomyopathy, Dilated / Q000235:genetics / Q000378:metabolism*; D002478:Cells, Cultured; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D017240:Mitochondrial Myopathies / Q000235:genetics / Q000378:metabolism*; D009154:Mutation; D009503:Neutropenia / Q000235:genetics / Q000378:metabolism; D010715:Phosphatidylglycerols / Q000737:chemistry / Q000378:metabolism*; D010743:Phospholipids / Q000378:metabolism*; D012016:Reference Values; D012867:Skin / Q000378:metabolism*; D013577:Syndrome; D014960:X Chromosome
D002308:Cardiolipins; D010715:Phosphatidylglycerols; D010743:Phospholipids